Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients-Reference-Cited by-同舟云学术

Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients

Published:2021-10 Issue:10310 Volume:398 Page:1482-1484
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Prendecki Maria,Thomson Tina,Clarke Candice L,Martin Paul,Gleeson Sarah,De Aguiar Rute Cardoso,Edwards Helena,Mortimer Paige,McIntyre Stacey,Mokreri Donald,Cox Alison,Pickard Graham,Lightstone Liz,Thomas David,McAdoo Stephen P,Kelleher Peter,Willicombe Michelle

Funder

MRC

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients;Benotmane;Kidney Int,2021

2. Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients;Bertrand;J Am Soc Nephrol,2021

3. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA,2021

4. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients;Cucchiari;Am J Transplant,2021

5. Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants;Marion;Ann Intern Med,2021

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients;Vaccine;2024-11

2. Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study;BMC Infectious Diseases;2024-06-06

3. Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial;Vaccines;2024-06-03

4. Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes;Viruses;2024-04-26

5. A Different Perspective of COVID-19 Pandemic: Efficacy and Safety of mRNA Vaccines in Immunocompetent and Immunocompromised Individuals (Part 3);Experimental and Clinical Transplantation;2024-01